Tardive dyskinesia (TD) is a complex iatrogenic movement disorder caused by prolonged dopamine receptor antagonism, often occurring in individuals on long-term antipsychotic medications....
Jonathan Falletta,
PA-C, CAQ-Psych,
Physician Associate, DENT Neurologic Institute
Managing Tardive Dyskinesia: Early Detection and Effective Treatment Strategies
Tardive dyskinesia (TD) is an involuntary movement disorder caused by prolonged use of dopamine receptor-blocking agents, such as antipsychotic medications....
Jessica Jones,
DHSc, PA-C, CAQ-Psych,
Director of Didactic Education, College of Saint Mary
Advances in Tardive Dyskinesia Diagnosis and Treatment: Early Detection and VMAT2 Inhibitors
The clinical manifestations of tardive dyskinesia (TD) can be disruptive, with common symptoms including choreoathetotic and stereotypic movements, particularly in...
Aaron Zalewski,
MSN, PMHNP-BC,
Psychiatric-Mental Health Nurse Practitioner, H3-Hope Healing Health
Managing Tardive Syndrome: Diagnosis Challenges and Treatment Approaches
The underlying causes of tardive syndrome (TS) are not entirely understood, but hypotheses suggest dopaminergic receptor hypersensitivity and oxidative stress...
Aaron Zalewski,
MSN, PMHNP-BC,
Psychiatric-Mental Health Nurse Practitioner, H3-Hope Healing Health
Early Detection and Management of Tardive Dyskinesia in Patients Taking Dopamine-Receptor Blocking Agents
Tardive dyskinesia (TD) is a movement disorder commonly associated with dopamine-receptor blocking agents (DRBAs), including antipsychotics and metoclopramide....
Jessica Jones,
DHSc, PA-C, CAQ-Psych,
Director of Didactic Education, College of Saint Mary
